Raquel Laza-Briviesca

The Royal Free Hospital The Anthony Nolan Research Institute

关注

立即认领

关注

立即认领

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Figure from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Pedro Rocha,Jiexin Zhang,Raquel Laza-Briviesca,Alberto Cruz-Bermúdez,Neus Bota-Rabassedas,Beatriz Sanchez-Espiridon,Katsuhiro Yoshimura,Carmen Behrens,Wei Lu,Ximing Tang,Apar Pataer,Edwin R. Parra,Cara Haymaker,Junya Fujimoto,Stephen G. Swisher,John V. Heymach,Don L. Gibbons,J. Jack Lee,Boris Sepesi,Tina Cascone,Luisa M. Solis,Mariano Provencio,Ignacio I. Wistuba,Humam Kadara

crossref（2023）

引用0浏览0引用

Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Pedro Rocha,Jiexin Zhang,Raquel Laza-Briviesca,Alberto Cruz-Bermúdez,Neus Bota-Rabassedas,Beatriz Sanchez-Espiridon,Kazuhito Funai,Carmen Behrens,Wei Lü,Ximing Tang,Apar Pataer,Edwin R. Parra,Cara Haymaker,Junya Fujimoto,Stephen G. Swisher,John V. Heymach,Don L. Gibbons, John Lee,Boris Sepesi,Tina Cascone,Luisa M. Solis,Mariano Provencio,Ignacio I. Wistuba,Humam Kadara

openalex（2023）

引用0浏览0引用

Abstract 6152: Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy and Chemoimmunotherapy in Resectable NSCLC

Pedro Rocha,Jiexin Zhang,Raquel Laza‐Briviesca,Alberto Cruz-Bermúdez,Katsuhiro Yoshimura,Carmen Behrens,Apar Pataer,Edwin R. Parra-Cuentas,Cara Haymaker,Junya Fujimoto,Stephen G. Swisher,John V. Heymach,Don L. Gibbons,John Lee,Boris Sepesi,Tina Cascone,Luisa M. Solis,Mariano Provencio,Ignacio I. Wistuba,Humam Kadara

Cancer Research（2022）

引用8浏览0引用

Blood Biomarkers Associated to Complete Pathological Response on NSCLC Patients Treated with Neoadjuvant Chemoimmunotherapy Included in NADIM Clinical Trial

Raquel Laza-Briviesca,Alberto Cruz-Bermudez,Ernest Nadal,Amelia Insa,Maria del Rosario Garcia-Campelo,Gerardo Huidobro,Manuel Domine,Margarita Majem,Delvys Rodriguez-Abreu,Alex Martinez-Marti,Javier De Castro Carpeno,Manuel Cobo,Guillermo Lopez Vivanco,Edel Del Barco,Reyes Bernabe Caro,Nuria Vinolas,Isidoro Barneto Aranda,Santiago Viteri,Bartomeu Massuti,Marta Casarrubios,Belen Sierra-Rodero,Carlos Tarin,Aranzazu Garcia-Grande,Cara Haymaker,Ignacio I. Wistuba,Atocha Romero,Fernando Franco,Mariano Provencio

Clinical and translational medicine（2021）

引用21浏览0WOS引用

Pretreatment Tissue TCR Repertoire Evenness is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

Marta Casarrubios,Alberto Cruz-Bermudez,Ernest Nadal,Amelia Insa,Maria del Rosario Garcia Campelo,Martin Lazaro,Manuel Domine,Margarita Majem,Delvys Rodriguez-Abreu,Alex Martinez-Marti,Javier de Castro-Carpeno,Manuel Cobo,Guillermo Lopez-Vivanco, Edel Del Barco,Reyes Bernabe Caro,Nuria Vinolas,Isidoro Barneto Aranda,Santiago Viteri,Bartomeu Massuti,Miguel Barquin,Raquel Laza-Briviesca,Belen Sierra-Rodero,Edwin R. Parra,Beatriz Sanchez-Espiridion,Pedro Rocha,Humam Kadara,Ignacio I. Wistuba,Atocha Romero,Virginia Calvo,Mariano Provencio

Clinical cancer research（2021）

引用27浏览0WOS引用

Clinical and Molecular Parameters Associated to Pneumonitis Development in Non-Small-cell Lung Cancer Patients Receiving Chemoimmunotherapy from NADIM Trial

Belen Sierra-Rodero,Alberto Cruz-Bermudez,Ernest Nadal,Yago Garitaonaindia,Amelia Insa,Joaquin Mosquera,Joaquin Casal-Rubio,Manuel Domine,Margarita Majem,Delvys Rodriguez-Abreu,Alex Martinez-Marti,Javier De Castro Carpeno,Manuel Cobo,Guillermo Lopez Vivanco,Edel Del Barco,Reyes Bernabe Caro,Nuria Vinolas,Isidoro Barneto Aranda,Santiago Viteri,Bartomeu Massuti,Raquel Laza-Briviesca,Marta Casarrubios,Aranzazu Garcia-Grande,Atocha Romero,Fernando Franco,Mariano Provencio

Journal for ImmunoTherapy of Cancer（2021）

引用4浏览0WOS引用

OA20.02 Pre-Treatment Levels of Ctdna for Long-Term Survival Prediction in Stage IIIA NSCLC Treated with Neoadjuvant Chemo-Immunotherapy

A. Romero,E. Nadal, R. Serna,A. Insa,M. R. Garcia Campelo,C. Benito,M. Domine,M. Majem,D. Rodriguez Abreu,A. Martinez-Marti,J. De Castro,M. Cobo,G. Lopez Vivanco,E. Del Barco,R. Bernabe,N. Vinolas,I. Barneto,S. Viteri,E. Pereira,A. Royuela,M. Casarrubios,V. Calvo,R. Laza-Briviesca,B. Massuti,A. Cruz,E. Sanchez-Herrero,M. Provencio

Journal of thoracic oncology（2021）

引用19浏览0引用

Abstract 560: High Levels of Baseline Ctdna Constitute a Poor Prognostic Factor in Progression-Free Survival in Patients Receiving Neo-Adjuvant Chemo-Immunotherapy: Results from NADIM Clinical Trial

Mariano Provencio,Roberto Serna-Blasco,Ernest Nadal,Amelia Insa,M. Rosario Garcia-Campelo,Diego Pereiro Corbacho,Manuel Domine,Margarita Majem,Delvys Rodriguez-Abreu,Alex Martinez-Marti,Javier de Castro,Manuel Cobo,Guillermo Lopez-Vivanco,Edel del Barco,Reyes Bernabe,Nuria Vinolas,Isidoro Barneto,Santiago Viteri,Eva Pereira,Ana Royuela,Marta Casarrubios,Clara Salas,Edwin R. Parra,Ignacio Wistuba,Virginia Calvo,Raquel Laza-Briviesca,Bartomeu Massuti,Alberto Cruz-Vermudez,Atocha Romero

CANCER RESEARCH（2021）

引用0浏览0引用

KRAS P.g12c Mutation Occurs in 1% of EGFR-mutated Advanced Non-Small-cell Lung Cancer Patients Progressing on a First-Line Treatment with a Tyrosine Kinase Inhibitor

R. Serna-Blasco,E. Sanchez-Herrero,S. Sanz-Moreno,A. Rodriguez-Festa, E. Garcia-Veros,M. Casarrubios,B. Sierra-Rodero,R. Laza-Briviesca,A. Cruz-Bermudez,X. Mielgo-Rubio, A. Sanchez-Hernandez, E. A. Uribelarrea,V. Calvo A. Romero,M. Provencio

ESMO open（2021）

引用6浏览0WOS引用

The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy

Alberto Cruz-Bermúdez,Raquel Laza-Briviesca,Marta Casarrubios,Belén Sierra-Rodero,Mariano Provencio

Biomedicines（2021）

引用6浏览0引用

加载更多

作者统计

#Papers: 41

#Citation: 904

H-Index: 12

G-Index: 26

Sociability: 5

Diversity: 3

Activity: 34

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn